Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Context: Tamoxifen, a selective estrogen receptor modulator, suppresses GH secretion in women but not in men. It increases testosterone levels in men. As GH and testosterone stimulate fat metabolism, the metabolic consequences of tamoxifen may be greater in women than in men. Objective: To determine whether tamoxifen suppresses fat oxidation (Fox) to a greater degree in women than in men. Design: An open-label study of ten healthy postmenopausal women and ten healthy men receiving 2-week treatment with tamoxifen (20 mg/day). Endpoint measures: GH response to arginine stimulation, serum levels of IGF1, testosterone and LH (men only), sex hormone binding globulin (SHBG) and whole body basal and postprandial Fox. Results: In women, tamoxifen significantly reduced the mean GH response to arginine stimulation (Δ −87%,P<0.05) and circulating IGF1 levels (Δ −23.5±5.4%,P<0.01). Tamoxifen reduced postprandial Fox in women (Δ −34.6±10.3%;P<0.05). In men, tamoxifen did not affect the GH response to arginine stimulation but significantly reduced mean IGF1 levels (Δ −24.8±6.1%,P<0.01). Tamoxifen increased mean testosterone levels (Δ 52±14.2%;P<0.01). Fox was not significantly affected by tamoxifen in men. Conclusion: Tamoxifen attenuated the GH response to stimulation and reduced postprandial Fox in women but not in men. We conclude that at a therapeutic dose, the suppressive effect of tamoxifen on fat metabolism is gender-dependent. Higher testosterone levels may mitigate the suppression of GH secretion and Fox during tamoxifen treatment in men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, there is little evidence that estrogen replacement increases postprandial fat oxidation in hypogonadal women.”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [119]
In the citing paper
“No relationship was found between plasma estradiol concentrations and fat oxidation in postmenopausal women receiving hormone replacement therapy (HRT) (119)”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [119]
In the citing paper
“With regard to postprandial carbohydrate oxidation, there appear to be neither acute (114–118) or chronic (20, 21, 119–121) effects of sex hormones.”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [119]
Citations
Cites
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Effects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464
Mauras, N., Hayes, V., Welch, S., Rini, A., Helgeson, K., Dokler, M., Veldhuis, J. D., & Urban, R. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4892 · Cited by 368
Wang, C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2839 · Cited by 359
The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients
Gibney, J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2596 · Cited by 324
Adjuvant Treatment and Onset of Menopause Predict Weight Gain After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., McCready, D., Koo, J., Sidlofsky, S., Trudeau, M., Hood, N., & Redwood, S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.120 · Cited by 319
Mauras, N. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1886 · Cited by 280
Leung, K. C., Doyle, N., Ballesteros, M., Sjogren, K., Watts, C. K. W., Low, T. H., Leong, G. M., Ross, R. J. M., & Ho, K. K. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337600100 · Cited by 218
Self-citationO'Sullivan, A. J., Crampton, L. J., Freund, J., & Ho, K. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2773 · Cited by 210
Self-citation
Research works printed but not linked: 1
- 10.1210/jc.76.6.1407 · doi:10.1210/jc.76.6.1407 · Paper page
Cited by
Sex steroids and the GH axis: implications for the management of hypopituitarism
Birzniece, V., & Ho, K. K. Y. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.003 · Cited by 65
Self-citationThuzar, M., Law, W. P., Ratnasingam, J., Jang, C., Dimeski, G., & Ho, K. K. Y. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13157 · Cited by 58
“Resting metabolic rate (RMR) and substrate metabolism were quantified after an overnight 10-hour fast by indirect calorimetry using a metabolic monitor (ParvoMedics, Sandy, Utah), which was calibrated against standard gases before each study, as previously described.(30,31) Subjects rested for 30 minutes in a supine p…”
MethodSelf-citationCosta, D. N., Santosa, S., & Jensen, M. D. (2025) · Physiological Reviews · doi:10.1152/physrev.00008.2024 · Cited by 34
Developing Modern Pain Therapies
Manion, J., Waller, M. A., Clark, T., Massingham, J. N., & Neely, G. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01370 · Cited by 39
King, S. E., Nilsson, E. E., Beck, D., & Skinner, M. K. (2019) · Adipocyte · doi:10.1080/21623945.2019.1693747 · Cited by 27
Metadata
- Authors
- Birzniece, V., & Ho, K. K. Y.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Corresponding author
- Ho, Ken K Y
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10
- Volume
- 173
- Issue
- 4
- Pages
- 479-487
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W1929970298
- Cited by
- 8
- References
- 39
- Citations by year
- 2025: 1 · 2019: 2 · 2017: 4 · 2016: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- tamoxifen, estrogen receptor antagonism, selective estrogen receptor modulators, fat oxidation, growth hormone secretion, insulin-like growth factor I, testosterone, sex differences, postmenopausal women, arginine stimulation, sex hormone-binding globulin, gonadal axis
- MeSH terms
- Adipose Tissue, Aged, Estrogen Antagonists, Female, Humans, Insulin-Like Growth Factor I, Luteinizing Hormone, Male, Middle Aged, Oxidation-Reduction, Sex Characteristics, Sex Hormone-Binding Globulin, Tamoxifen, Testosterone, Postmenopause, Human Growth Hormone, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes. https://app.cochat.ai/papers/10.1530/eje-15-0426
- The paper
- Birzniece, V., & Ho, K. K. Y. (2015). Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes. European Journal of Endocrinology. https://doi.org/10.1530/eje-15-0426
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.